Skip to main content

Table 1 Association between clinicopathological factors and SALL4 expression in ESCC patients

From: Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma

Parameters

Number

SALL4 expression

P-value

 

High group

Low group

Age

    

 ≥60

94

75

19

0.2594

 <60

39

27

12

Gender

    

 Male

87

70

17

0.1965

 Female

46

32

14

Stage

    

 I + IIa

92

66

26

0.0477 *

 IIb + III + IV

41

36

5

Tumor invasion

    

 T1 + T2

64

46

18

0.2244

 T3

69

56

13

Lymph node metastasis

 N0

95

67

28

0.0068 **

 N1 + N2

38

35

3

Histological Grade

    

 Well differentiated

33

23

10

0.0648

 Moderately differentiated

78

58

20

 Poorly differentiated

22

21

1

  1. * P <0.05, ** P <0.01